Literature DB >> 2187123

Cumulative bone marrow stromal damage caused by X-irradiation and cytosine-arabinoside in leukemic mice.

Z Ben-Ishay1, G Prindull, S Yankelev, S Sharon.   

Abstract

A study of treated murine acute myeloid leukemia (AML) with an emphasis on the bone marrow stromal function is reported. Leukemia was induced in C57Bl mice through intraperitoneal (i.p.) inoculation of C-1498 myelogenous leukemic cells. The leukemic mice were administered: (1) total body lethal X-irradiation (t.b.i.); (2) two i.p. cytosine-arabinoside (Ara-C) injections followed by X-irradiation. Control mice received similar regimens. Bone marrow of experimental and control mice was processed for stromal cell cultures (SCC) and in vitro engraftment of hematopoietic cells onto the cultures. The results of this study indicate that the bone marrow stromal deficiency which occurs in leukemia is aggravated by Ara-C and irradiation treatments. Moreover, SCC of treated leukemic mice sustain in vitro hematopoiesis only to a limited degree. Stromal deficiency, as possible cause for graft failure in bone marrow transplanted leukemic patients, is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2187123     DOI: 10.1007/bf03000491

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  21 in total

1.  Consequences of extremely high doses of irradiation on bone marrow stromal cells and the release of hematopoietic growth factors.

Authors:  R J Gualtieri
Journal:  Exp Hematol       Date:  1987-10       Impact factor: 3.084

2.  A functional defect in irradiated adherent layers from chronic myelogenous leukemia long-term marrow cultures.

Authors:  M Takahashi; A Keating; J W Singer
Journal:  Exp Hematol       Date:  1985-10       Impact factor: 3.084

3.  Effects of chemotherapeutic agents on hemopoietic stromal tissue: I. Effects of cyclophosphamide and bleomycin on hemopoiesis in subcutaneous femur implants.

Authors:  S S Adler; R D Kuznetsky
Journal:  Exp Hematol       Date:  1984-03       Impact factor: 3.084

4.  Radiation damage to femoral hemopoietic stroma measured by implant regeneration and quantitation of fibroblastic progenitors.

Authors:  A H Piersma; R E Ploemacher; K G Brockbank
Journal:  Exp Hematol       Date:  1983-10       Impact factor: 3.084

5.  Suppression of marrow stromal cells and microenvironmental damage following sequential radiation and cyclophosphamide.

Authors:  L M Wathen; S A Knapp; R L DeGowin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-07       Impact factor: 7.038

6.  Incidence and characteristics of colony-forming units fibroblasts (CFU-F) in the bone marrow of weanling mice treated with cytosine arabinoside and phenylhydrazine: correlation with CFU-S, progenitors of diffusion-chamber colonies (CFU-D), and CFU-C.

Authors:  Z Ben-Ishay; A Borenstein; S Sharon; G Prindull
Journal:  Int J Cell Cloning       Date:  1983-10

7.  Effects of chemotherapy on bone marrow stroma in mice with acute myelogenous leukemia. Correlation with CFU-C and CFU-D.

Authors:  Z Ben-Ishay; G Prindull; S Sharon; A Borenstein
Journal:  Leuk Res       Date:  1985       Impact factor: 3.156

8.  Bone marrow stromal deficiency in acute myeloid leukemia in mice.

Authors:  Z Ben-Ishay; G Prindull; A Borenstein; S Sharon
Journal:  Leuk Res       Date:  1984       Impact factor: 3.156

9.  Pre-CFU-f: young-type stromal stem cells in murine bone marrow following administration of DNA inhibitors.

Authors:  Z Ben-Ishay; G Prindull; S Sharon; A Borenstein
Journal:  Int J Cell Cloning       Date:  1986-03

10.  Changes of bone marrow stromal cells (MSC) in mice after drug induced eradication of hematopoietic cells: in vitro effects on normal bone marrow.

Authors:  Z Ben-Ishay; G Prindull; S Sharon
Journal:  Biomed Pharmacother       Date:  1982       Impact factor: 6.529

View more
  1 in total

1.  Recurrent growth factor starvation promotes drug resistance in human leukaemic cells.

Authors:  K Saeki; E Okuma; A Yuo
Journal:  Br J Cancer       Date:  2002-01-21       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.